Merck & Company, Inc. vs Mettler-Toledo International, I — Stock Comparison
Merck & Company, Inc. (MRK) and Mettler-Toledo International, I (MTD) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merck & Company, Inc. narrowly edges Mettler-Toledo International, I on Q·Score (6.4 vs 6.1 out of 10), led by Sentiment (7.4 vs 4.6) and Health (7 vs 4.5). Mettler-Toledo International, I scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MTD (+9.2%) than for MRK (+6.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Strong profitability with 22% net profit margins.
⚠ high leverage at 166.7× debt-to-equity.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MRK vs MTD: which stock scores better overall?
Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.4/10 versus Mettler-Toledo International, I (MTD) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MRK or MTD?
Mettler-Toledo International, I (MTD) scores higher on Growth (7/10 vs 6.4/10). Merck & Company, Inc. reports revenue growth (5.1% YoY) while Mettler-Toledo International, I reports (4.5% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MRK or MTD more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (7/10 vs 6.5/10). MRK trades at 15.1× P/E versus MTD at 25.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MRK vs MTD?
There are 26 analysts covering MRK with a consensus price target of $152.96, and 14 analysts covering MTD with a consensus target of $1452.50. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MRK or MTD?
Mettler-Toledo International, I (MTD) scores higher on Quality (7.3/10 vs 4.9/10). Net profit margin: MRK at 4.8%, MTD at 21.9%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MRK or MTD?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 4.5/10). Market beta: MRK at 0.23, MTD at 1.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MRK and MTD?
Merck & Company, Inc. (MRK) has a market capitalisation of $354.8B, while Mettler-Toledo International, I (MTD) has a market cap of $26.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MRK or MTD pay dividends?
MRK pays a dividend yield of 2.35%, while MTD does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →